{"id":781837,"date":"2023-09-05T09:17:18","date_gmt":"2023-09-05T13:17:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/"},"modified":"2023-09-05T09:17:18","modified_gmt":"2023-09-05T13:17:18","slug":"myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/","title":{"rendered":"Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference"},"content":{"rendered":"<h2>\nMyriad to also host Investor Day in South San Francisco in September<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">SALT LAKE CITY, Sept.  05, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_yrho4UFgin8PfD_OknuIhjX_S-492hgWEUbeT2cbNXwJQOV9lZT5UcXlKq2p-XLCY5z4GycEE0Z7zS6BXhgIg==\" rel=\"nofollow noopener\" target=\"_blank\">Myriad Genetics, Inc.<\/a>, (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced management will participate in the Morgan Stanley 21<sup>st<\/sup> Annual Global Healthcare Conference with a fireside chat on Wednesday, Sept. 13, 2023 at 2:15 p.m. EDT.<\/p>\n<p>On Sept. 19, Myriad will host an in-person <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q4CH3smr5k7eU-RJ6V-EdgcXeyUlmideueOIbxj8mqbphg_Wt8_-d_8NRlgyjkpEw1O5eLHq6A7JZaFy-KzAXbvJlhktjq7PIJnqwcwnNekngTJ2nLE2jNFNQDsxlUy0LHib4DBnGh4ZvXX9wX83JzFm1PZWXOHIErp8KWRIIb0=\" rel=\"nofollow noopener\" target=\"_blank\">Investor Day<\/a> at the newly constructed Dr. Walter Gilbert Innovation Center in South San Francisco. Paul J. Diaz, president and CEO, and other members of the Myriad executive leadership team will discuss commercialization strategies, clinical advancement and new product pipeline, and long-term financial goals.<\/p>\n<p>The Morgan Stanley fireside chat will be available on Myriad\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fDWogLvMUCvHpjIYFOa2eR4Onfz4qeJ8b3mz5GsoA6pOe241UQjdtRri_-I6g1FIFSXxLkDGNfboANl1Om4uVRZqV7t_GrFfw147E0l9S4E=\" rel=\"nofollow noopener\" target=\"_blank\">investor.myriad.com<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eFQiW3hLJB-vVHAKAKE8FNGgghpIgM0MGNPJ3JO8e5bDCAZp_vTynxYcP4fLHhaArddiEISk4lYM-HgOv5viLg==\" rel=\"nofollow noopener\" target=\"_blank\">.<\/a> For those unable to attend Myriad\u2019s Investor Day, the presentation and Q&amp;A will also be available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fDWogLvMUCvHpjIYFOa2eS5Caqroar0JypVy2bKOm3_jy3u6hSdtwAFmpd9j5j0JvnK99x3nDicy2cvlzvFYFXKX1sAIV_0Uahs5Gho2e8I=\" rel=\"nofollow noopener\" target=\"_blank\">investor.myriad.com<\/a>.<\/p>\n<p>\n        <strong>About Myriad Genetics<\/strong><br \/>\n        <br \/>Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Nh_GAwR8Mto8SWvYrVRwTpdtRhbaHQ88ZgUSMw8ZmNyFOFw-R2MK4qJdSofzKGzX99q5uPgMUOvx1dSvy5ZLBteKIeFQcxJu7pnWqZvLuRqWty08Fv440hKJcrGLlwcQfoll5gelJIb1mlQXQZZ39JDyQs_P-0Pz16MzHDxBK17GKCatFVg201TG8aIro5imxSjs-H2BVKCnMCaY4ggCJQt9hchiokoJ93X0x8BqDAQ=\" rel=\"nofollow noopener\" target=\"_blank\">www.myriad.com<\/a>.\u00a0\u00a0<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:50%;width:50%;min-width:50%;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>Media Contact:<\/strong><br \/>\n            <br \/>Glenn Farrell<br \/>(385) 318-3718<br \/>PR@myriad.com<\/td>\n<td style=\"max-width:50%;width:50%;min-width:50%;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>Investor Contact:<\/strong><br \/>\n            <br \/>Matt Scalo<br \/>(801) 584-3532<br \/>IR@myriad.com<\/td>\n<\/tr>\n<\/table>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNTIzNCM1Nzk0NzQ2IzIwMDc4ODc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDc4NDQ1ZTctYjMxZi00YTRlLTgwZDMtNTU1NmQwOTNkNDg0LTEwMTk0NjA=\/tiny\/Myriad-Genetics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Myriad to also host Investor Day in South San Francisco in September SALT LAKE CITY, Sept. 05, 2023 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced management will participate in the Morgan Stanley 21st Annual Global Healthcare Conference with a fireside chat on Wednesday, Sept. 13, 2023 at 2:15 p.m. EDT. On Sept. 19, Myriad will host an in-person Investor Day at the newly constructed Dr. Walter Gilbert Innovation Center in South San Francisco. Paul J. Diaz, president and CEO, and other members of the Myriad executive leadership team will discuss commercialization strategies, clinical advancement and new product pipeline, and long-term financial goals. The Morgan Stanley fireside chat will be &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-781837","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Myriad to also host Investor Day in South San Francisco in September SALT LAKE CITY, Sept. 05, 2023 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced management will participate in the Morgan Stanley 21st Annual Global Healthcare Conference with a fireside chat on Wednesday, Sept. 13, 2023 at 2:15 p.m. EDT. On Sept. 19, Myriad will host an in-person Investor Day at the newly constructed Dr. Walter Gilbert Innovation Center in South San Francisco. Paul J. Diaz, president and CEO, and other members of the Myriad executive leadership team will discuss commercialization strategies, clinical advancement and new product pipeline, and long-term financial goals. The Morgan Stanley fireside chat will be &hellip; Continue reading &quot;Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-05T13:17:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNTIzNCM1Nzk0NzQ2IzIwMDc4ODc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference\",\"datePublished\":\"2023-09-05T13:17:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\\\/\"},\"wordCount\":238,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNTIzNCM1Nzk0NzQ2IzIwMDc4ODc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\\\/\",\"name\":\"Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNTIzNCM1Nzk0NzQ2IzIwMDc4ODc=\",\"datePublished\":\"2023-09-05T13:17:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNTIzNCM1Nzk0NzQ2IzIwMDc4ODc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNTIzNCM1Nzk0NzQ2IzIwMDc4ODc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference - Market Newsdesk","og_description":"Myriad to also host Investor Day in South San Francisco in September SALT LAKE CITY, Sept. 05, 2023 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced management will participate in the Morgan Stanley 21st Annual Global Healthcare Conference with a fireside chat on Wednesday, Sept. 13, 2023 at 2:15 p.m. EDT. On Sept. 19, Myriad will host an in-person Investor Day at the newly constructed Dr. Walter Gilbert Innovation Center in South San Francisco. Paul J. Diaz, president and CEO, and other members of the Myriad executive leadership team will discuss commercialization strategies, clinical advancement and new product pipeline, and long-term financial goals. The Morgan Stanley fireside chat will be &hellip; Continue reading \"Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-05T13:17:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNTIzNCM1Nzk0NzQ2IzIwMDc4ODc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference","datePublished":"2023-09-05T13:17:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/"},"wordCount":238,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNTIzNCM1Nzk0NzQ2IzIwMDc4ODc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/","name":"Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNTIzNCM1Nzk0NzQ2IzIwMDc4ODc=","datePublished":"2023-09-05T13:17:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNTIzNCM1Nzk0NzQ2IzIwMDc4ODc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNTIzNCM1Nzk0NzQ2IzIwMDc4ODc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-morgan-stanley-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=781837"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781837\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=781837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=781837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=781837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}